PATENT CLAIM ANALYSIS

Application Number: 16068317
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "230200"]

Abstract:
The present invention provides, inter alia, methods for treating or preventing a disorder in a subject exposed to an agent that antagonizes the serotonin reuptake transporter (SERT), such as an SSRI, in utero or by consumption by the subject of breast milk from the subject's mother, by administering a 5-HT4 receptor antagonist, for example, to the subject's mother.

Claim (Index 23):
The method of  claim 22 , wherein the 5-HT4 receptor antagonist is administered to the subject's mother and a therapeutically effective amount of the 5-HT4 receptor antagonist is passed to the subject through the subject's mother's breast milk.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 95.0
- Lexical Diversity: 1.48936
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12375393', '13066590', '13866145', '14949490', '11629797']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7616608956622258
- 35 USC 102 Novelty (BERT): 0.519656187027101
- Combined Prediction Score: 0.7374604247987133
- Mean Citation Score: 228.982876
- Max Citation Score: 258.06296000000003
- Similarity Product: 142.6555429850531

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test